ÂÜÀòÂÒÂ×

Dr. M¨¹nchbach has been a Managing Partner and Investment Advisor Private Equity at BB Biotech Ventures and Bellevue Asset Management since 2004. He has been an active venture capitalist since the late 90¡¯s investing in life science companies across all stages and types. Prior to joining Bellevue Group, he was Investment Manager at BioMed, HBM, and NMT. Dr. M¨¹nchbach¡¯s past and current board assignments include Bellevue¡¯s most successful private biopharmaceutical investments, such as Radius Health, Molecular Partners, Optimer Pharmaceuticals, Axovan, and Glycart. Dr. M¨¹nchbach holds a PhD in Protein Chemistry, an MSc in Biochemistry, and a Masters in Industrial Engineering and Management from the Swiss Federal Institute of Technology (ETH), Z¨¹rich.